SGLT1/SLC5A1 Antibody - Azide Free

Western Blot: SGLT1/SLC5A1 Antibody [NBP2-20338] -

Various whole cell extracts (30 ug) were separated by 7.5% SDS-PAGE, and the membrane was blotted with SGLT1 antibody [N3C3] (NBP2-20338) diluted at 1:1000. The HRP-conjugated anti-rabbit IgG antibody was used to detect the primary antibody.

Western Blot: SGLT1/SLC5A1 Antibody - Azide Free [NBP2-20338] -

Proximal tubule gluconeogenesis and glucose transporters—(A) Glucose concentration in the medium from aliquots of PT-enriched suspensions (n = 6–7/mice/sex/genotype undergoing three potential ex vivo treatments in duplicate) incubated for 1 h with gluconeogenic substrates in the presence or absence of gluconeogenic stimulators, i.e., cyclic AMP and dexamethasone or insulin; * indicates a significant difference between groups (by three-way ANOVA with repeated measures for treatment); (B) Western blots of cortex homogenates (n = 6/group) probed with antibodies against the three rate-limiting enzymes in gluconeogenesis (PEPCK, FBP1, and G6PC), the sodium glucose cotransporters (SGLT1 and SGLT2), and the sodium-coupled neutral amino acid transporter type 3 (SNAT3); (C) summary (mean +/- sem) of the Ponceau-Red-stain-normalized band densities for each of the blots with the mean of wild-type males (WTMs) set to 1.0; letters above bars indicate results of Tukey’s multiple comparison test (only conducted when a main factor < 0.05) with “A" assigned to the highest mean and all means not different from it, followed by “B", etc. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/37175762), licensed under a CC-BY license. Not internally tested by Novus Biologicals.